5,000 ICU patients to help unlock secrets of critical illness

NCT ID NCT04502511

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is watching 5,000 adult ICU patients to understand why some develop more severe organ failure than others. Researchers will track patients' health and quality of life for a year. The goal is to find new clues that could one day lead to better treatments for critical illness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better predict which ICU patients are at highest risk for severe organ failure, potentially leading to more personalized care.

What could go wrong

This is an observational study, so it cannot prove cause and effect. It may not identify clear risk factors, and results may not apply to all ICU patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORGAN FAILURE, MULTIPLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness multiple organ dysfunction syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Medical Center Groningen

    RECRUITING

    Groningen, Provincie Groningen, 9713GZ, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••